How many new technology evaluations did your organization conduct in 2011?
decline in revenue caused by the patent cliffs has resulted in the pharma
giants slashing their research and development budgets. The resulting slowdown in innovation has left
the future looking bleak.
Eckhard von KeutzHead Global Early Development, Bayer HealthCare
View all Advisory Board members